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68Objective: The natural history of small-to-moderate size ascending aortic aneurysms is poorly understood. To
follow these patients better, we have developed a method to objectively and reproducibly measure ascending
aortic volume on the basis of gated contrast computed tomography scans.
Methods: From 2009 to 2011, 507 patients were referred for management of ascending aortic aneurysms. A
total of 232 patients (46%) with small-to-moderate size aneurysms who did not have compelling indications
for operation had measurement(s) of ascending aortic and total aortic volume; 166 patients had more than 1
scan, allowing measurement of growth. A total of 66 patients admitted to the emergency department without
ascending aortic pathology served as a reference group.
Results: None of the patients experienced rupture, dissection, or death; 3 patients ultimately underwent opera-
tion. Ascending aortic volume and volume/total aortic volume differed for the surveillance and reference groups:
132.8  39.4 mL versus 78.0  24.5 mL; 38.3%  7.4% versus 29.1%  3.9%, respectively (both P<.001).
Diameters at the sinotubular junction andmid-ascending aortic were 4.1 0.6 cm and 4.4 0.6 cm, respectively,
for the surveillance group and 3.0 0.4 cm and 3.2 0.4 cm, respectively, for controls. The increase in ascending
aortic volumewas 0.95 4.5mL/year and 0.73% 3.7%/year (P¼ .007 and .012, respectively). Analysis of risk
factors for ascending aortic growth revealed only the use of antithrombotic medication as possibly significant.
Conclusions:Computed tomography volumemeasurements provide an objective method for ascertaining aortic
size and monitoring expansion. Patients with small-to-moderate ascending aortic aneurysms who are carefully
followed and managed appropriately have slow aneurysm growth and a small risk of rupture or dissection.
Annual computed tomography screening may not be indicated, and elective resection—absent other surgical in-
dications—is not necessary. The rupture/dissection risk for even larger aneurysms in carefully followed patients
may be lower than currently believed. (J Thorac Cardiovasc Surg 2014;147:68-74)Aortic aneurysm disease is the 15th most common cause of
death in individuals aged more than 65 years. On the
basis of a population study from 1980 to 1994, the incidence
of thoracic aortic aneurysms is described as 10.4 per 100,000
person-years, and the frequency of diagnosis is probably
now higher, given improved imaging techniques and an
aging population.1,2 The natural history of thoracic aortic
aneurysms is poorly understood. To decide on the
appropriate treatment strategy for each individual patient, it
is critical to be able to estimate the risk of rupture or acute
dissection because rupture and dissection are often lethal,
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The Journal of Thoracic and Cardiovascular SurgeAneurysms of the ascending aorta are often indolent and
frequently discovered incidentally.1 How should we pro-
ceed with small-to-moderate size aneurysms of the
ascending aorta? Guidelines suggest intervention at a diam-
eter of 5.5 cm because the risk of rupture of an aneurysm is
known to increase dramatically with ascending aortic (AA)
size greater than 6 cm.5,6 However, it is important to bear in
mind that size and growth are determining factors only in
asymptomatic patients: Patients with pain or uncontrolled
hypertension and those with connective tissue disease or a
family history of dissection are at high risk and need to be
treated differently.5,7
Early reports of growth rates have concluded that
thoracic aortic aneurysms usually grow slowly,8-12 and it
has been assumed that more rapid growth puts the patient
at increased risk even when the usual diameter thresholds
for operation have not been reached. But growth needs to
be monitored, and to be reliable, measurements must be
performed in an accurate, reproducible manner. Imaging
techniques include echocardiography (transthoracic and
transesophageal), computed tomography (CT), magnetic
resonance imaging, and angiography.6 Each one illustrates
the aorta in a different way, allowing assessment of size and
shape. At the same time, each imaging technique hasry c January 2014
Abbreviations and Acronyms
AA ¼ ascending aortic
CT ¼ computed tomography
SD ¼ standard deviation
SE ¼ standard error
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of the aorta. Furthermore, measurements using different
imaging techniques are often hard to compare with one
another.
It is important to understand the natural history of
thoracic aneurysms, especially in the AA, to intervene
before a fatal complication occurs. To avoid being too
aggressive in cases in which an aneurysm is unlikely to
rupture or dissect, we must develop a reliable method to
evaluate size and serially monitor growth. We have
frequently observed that reported size changes in AA aneu-
rysms, usually increases, are due to measurements taken at
different levels or angles in serial studies. The ideal tech-
nique for measuring the aorta would remove as much
subjectivity as possible. Because of the methodological
problems involved in consistently measuring diameters, as
well as the conceptual inadequacy of describing a complex
3-dimensional structure with a single linear measurement,
we developed a more objective means of quantifying AA
size using volume measurements. We believe that this tech-
nique adds to the reliability of CT scan estimation of size
and growth, especially when comparison with earlier imag-
ing studies is difficult or impossible.MATERIALS AND METHODS
From 2009 to 2011, 232 patients (167male, 65 female) were referred for
management of AA aneurysms and advised to continue surveillance rather
than undergo operation. Aneurysms of small-to-moderate size, in the
absence of operative indications such as pain, a family history of aneurysm
with rupture or dissection, or evidence of recent aneurysm enlargement, or
a contraindication to operation such as the presence of other life-
threatening medical conditions, defined the surveillance group. All patients
underwent CT scans at the Mount Sinai Medical Center. Volume measure-
ments and measurements of aortic diameters were carried out. Patients
were excluded from the study if they had an aneurysm 5 cm or greater else-
where in the aorta, an aortic operation before the scans were undertaken, or
Marfan syndrome. A total of 66 patients admitted to the emergency depart-
ment (35 male/31 female) without AA pathology who had similar scans
served as a reference group. This retrospective analysis, using a review
of medical records, was approved by an institutional review board and
did not require individual patient consent.
Of the 232 surveillance patients, 166 had more than 1 scan, allowing the
calculation of growth rates; 157 patients had 2 scans, and 9 patients had 3
scans. A total of 971 patient-years was monitored. Only scans that were
more than 3 months apart were included in the analysis of growth rate.
To calculate growth rates, first and last measurements were taken in cases
of multiple CT scans. The median (range) time between the first and last
scans was 1.1 (0.4-4.3) years. During the observed interval, 273 other pa-
tients underwent elective AA operations at theMount Sinai Medical Center
on initial presentation.The Journal of Thoracic and CComputed Tomography Measurements
All measurements and divisions of the aorta into segments were under-
taken using Aquarius by TeraTecon, Inc (San Mateo, Calif) and carried out
by the same analyst (I.O.). The aorta for each patient was divided into 4
segments: ascending aorta, arch, descending aorta, and abdominal aorta.
The volumes of each separate segment were calculated using the dedicated
software. Segments were defined as follows: The ascending aorta extends
from the root to the proximal origin of the innominate artery, the arch ex-
tends between the proximal origins of the innominate and the left subcla-
vian artery, the descending aorta extends from the distal origin of the
left subclavian artery to the proximal origin of the celiac axis, and the
abdominal aorta extends from the celiac axis to the iliac bifurcation. The
planes separating the segments were drawn perpendicular to the central
axis of the aorta. The proximal extent of the ascending aorta was obtained
by trimming along the aortic valve manually in multiple planes. After the
regions of the aorta were segmented, each slice was compared with the
source dataset by the analyst to be sure that all areas of interest were
covered and correlated with the source data. The ascending aorta as defined
by this process is shown in Figure 1.
Because 95% of the subjects in the surveillance group had only 2 scans,
growth rates were estimated by calculating the increase in volume over
time between the scans, and extrapolating to obtain a yearly rate. Volumes
were analyzed and compared by segment and for the aorta as a whole. For
further analysis, the aorta was divided into 2 parts: the ascending aorta and
the distal aorta, including the arch and descending and abdominal aortas.
Statistical Analysis
Data are described as mean  standard deviation (SD) and percentage.
Wilcoxon, Mann–Whitney, chi-square, and t tests were used to compare
differences between groups. Linear regression using the least-squares
method was used to describe the relationship between the AA volume
and diameter, and the relationship between AAvolume growth rate and po-
tential predictors listed in Table 1. For the latter, factors that had a P value
less than .2 were further considered in the stepwise multivariate regression
analysis. All analyses were performed using SAS software version 9.2
(SAS Institute Inc, Cary, NC).
RESULTS
Patient Cohort
The mean age at the time of the first scan was 63.6 12.3
years in the surveillance group and 57.7 17.8 years in the
control group (P ¼ .014). Significantly more patients in the
surveillance group were male (35/66, 53% of the control vs
167/232, 72.0% of the surveillance patients; P ¼ .004) and
hypertensive (32/66, 48.5% in control vs 165/200, 81.5%,
in the surveillance group; information could not be obtained
for 32 patients; P<.001). Body mass index was 29.0  6.0
kg/m2 in controls and 28.5  4.9 kg/m2 in the surveillance
group (P ¼ .585). Some 31.8% of control patients (21/66)
had ever smoked versus 30.8% of the surveillance group
(56/180), with information missing for 52 of the surveil-
lance patients (P ¼ .916). Hyperlipidemia was diagnosed
in 21 of 49 control patients (42.9%), whereas 114 of 198 pa-
tients (57.6%) in the surveillance group had a confirmed
history of hyperlipidemia (P ¼ .064). Ten surveillance pa-
tients had chronic aortic type B dissection.
Clinical Outcome
None of the patients experienced rupture, dissection, or
death during the interval of surveillance. Three patients inardiovascular Surgery c Volume 147, Number 1 69
FIGURE 1. Three-dimensional reconstruction of thoracic aorta. The volume measurements we describe rely on construction of planes separating the aorta
segments according to a standard protocol, with trimming of the origin of the aorta around the aortic valve. The darkened area highlights the ascending aorta.
The defined part of the aorta is extracted from the image, and volume measurements were undertaken using the dedicated software.
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patient underwent aortic valve and AA replacement because
of an increase in the gradient of a stenotic bicuspid aortic
valve with concomitant severe regurgitation. The last CT
scan, undertaken 1 year before operation, showed an AA
volume of 118 mL, with a diameter at the aortic root of
37 mm. Another patient was followed for 4 years for AA
dilatation and aortic valve insufficiency before (basedTABLE 1. Possible predictors of ascending aortic growth (milliliters/
year)
Parameter
Frequency (%)
or mean value P value
Age 64 y .91
Male sex 71 .08*
BMI 29 kg/m2 .33
Systolic blood pressure 122 mm Hg .19*
Family history 22 .34
Ever smoked 31 .28
History of hypertension 82 .67
History of hyperlipidemia 57 .46
Bicuspid aortic valve 20 .39
Valve pathology 44 .69
Dissection 4 .75
Antihypertensive medication 84 .84
Beta-blocker 59 .96
Lipid-lowering medication 47 .50
Anticoagulant medication 56 .05y
Volume ascending aorta 133 mL .45
Volume of total aorta 350 mL .27
Volume ratio: ascending aorta/total 38 .64
BMI, Body mass index. *Correlated with increased growth (not significant in multi-
variate analysis). yIndependent predictor of decreased growth (also significant in
multivariate analysis).
70 The Journal of Thoracic and Cardiovascular Surgeprimarily on ventricular size) a Bentall operation was rec-
ommended and performed; the volume before the operation
was 185 mL, with a diameter of 52 mm. The third patient
had aortic valve insufficiency and coronary artery disease
in addition to an AA aneurysm.
The patient had been followed for approximately 2 years
before developing nonspecific chest pain and dyspnea on
exertion, prompting aortic valve repair, AA replacement,
and coronary artery bypass grafting. The AAvolume before
the operation was 151 mL, with a diameter of 46 mm.Volumes
The average volume of the entire aorta was 349.7  90.4
mL in surveillance patients, but only 267.1  72.9 mL in
controls (P< .001). The average volume of the AA was
132.8 39.4 mL in the surveillance group and significantly
lower in control patients: 78.0  24.5 mL (P<.001). The
volumes of the distal aorta (arch, descending aorta, and
abdominal aorta) were 216.9  68.2 mL in surveillance pa-
tients and 189.1 52.8 mL in controls (P<.001) (Figure 2).
The distribution of AA volumes in control and surveillance
patients is shown in Figure 3.Growth Rate
Only the AA had significant growth: 0.95  4.5 mL per
year (P ¼ .007) and 0.73%  3.7% per year (P ¼ .012).
The remaining distal aorta did not grow within the observed
interval: The growth rate was 0.03  7.0 mL per year
(P¼ .962; 0.02% 3.38% per year, P¼ .947). The growth
rate for the entire aorta was 0.98  9.41 mL per year
(P ¼ .183; 0.3%  2.85% per year; P ¼ .175).ry c January 2014
FIGURE 2. Comparison of volumes of ascending and distal aortas. The
average volumes of the ascending aorta, distal aorta, and entire aorta are
132.8  39.4 mL, 216.9  68.2 mL, and 349.7  90.4 mL, respectively,
for surveillance group and 78  24.5 mL, 189.1  52.8 mL, and 267.1
 72.9 mL, respectively, for control group. A significant difference was
found between the 2 groups for all 3 volumes. FIGURE 4. Ratio of AA volume compared with total aortic volume. The
ratiowas approximately 10% lower in the control group, with an average of
29.1% 3.9% compared with 38.3% 7.4% in patients with AA dilata-
tion. The ratio in patients with chronic dissection was lower than the
average in the surveillance group and ranged from 12% to 33%.
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To incorporate the length of the aorta in our analysis of
volumes and to allow correction for patient size, we
analyzed the ratio of the volume of the AA to the volume
of the entire aorta. The ratio was on average 10% lower
in control patients: 38.3% 7.4% in the surveillance group
and 29.1%  4.0% in controls (P<.001). The distribution
of volume ratios for control and surveillance patients is
shown in Figure 4.Diameter/Volume Comparisons
A plot of AA diameter at the right pulmonary artery in
relation to the AA volume in each scan of patients in theFIGURE 3. Distribution of AA volumes in surveillance and control
groups. Patients in the surveillance group had significantly higher volumes
(P<.001): The average was 132.8 39.4 mL in surveillance group and 78
 25 mL in control group. Volumes tended to be higher with increasing age
in both groups.
The Journal of Thoracic and Csurveillance group and in the only scan from each patient
in the control group is shown in Figure 5. A quadratic rela-
tionship fitted by linear regression using the least-squares
method is shown for the average relationship of volume
with diameter measured by a radiologist (volume
[mL] ¼ 7.41 [standard error {SE}, 40.24] þ 11.36 [SE,
19.0] 3 diameter [cm] þ 4.7 [SE, 2.2] 3 diameter
[cm]3 diameter [cm]). Thus, an aneurysm with a diameter
of 5 cm would have an average volume of 167 mL, and an
aneurysm with a diameter of 6 cm would have a volume of
230 mL. The average diameters of the control and surveil-
lance groups are shown in Table 2. The average diameter
at the right pulmonary artery was 4.4  0.6 cm for the sur-
veillance group and 3.2  0.4 cm for the control group
(P<.001).
Predictors of Growth Rate
A univariate analysis of gender; age at first scan; body
mass index; history of hypertension; history of hyperlipid-
emia; history of smoking; family history; bicuspid aortic
valve; systolic blood pressure; volume of the AA; volume
of the entire aorta; ratio of AA/total aorta; antihypertensive,
antilipidemic, and anticoagulant medications; intake of
beta-blocker; valve pathology including s/p aortic valve
replacement; and aortic dissection was undertaken. The
P value was less than .2 for male gender (P¼ .088), antico-
agulant medication (P ¼ .053), and systolic blood pressure
(P ¼ .188); thus, those factors were considered in the step-
wise regression. The stepwise regression identifiedardiovascular Surgery c Volume 147, Number 1 71
FIGURE 5. The AA diameter at the right pulmonary artery in relation to
the AAvolume found in each scan of patients in the surveillance group and
in the only scan from each patient in the control group. A quadratic rela-
tionship fitted by linear regression is shown for the average relationship
of volume and diameter. Thus, an aneurysm with a diameter of 5 cm would
have a volume of 167 mL, and an aneurysm with a diameter of 6 cm would
have a volume of 230 mL.
Acquired Cardiovascular Disease Geisb€usch et al
A
C
Danticoagulant medication as the sole significant predictor of
growth rate. Specifically, use of an anticoagulant drug was
associated with a decreased growth rate (Table 1). Patients
taking low-dose aspirin, warfarin, or clopidogrel were
included in this group; most were taking aspirin.
Rupture and Dissection Risk
The patients in the surveillance group were followed for
a total of 971 patient-years. No instance of rupture or
dissection occurred, suggesting that the risk of these
adverse outcomes is less than 0.1% per patient-year. How-
ever, 3 patients were withdrawn from the study to undergo
operation (albeit all for hemodynamic reasons rather than
change in the size of the aneurysm). If one argued that all
3 patients would have sustained rupture/dissection if opera-
tion had not been performed, the risk would increase only
to 0.3% per patient-year.
DISCUSSION
Our observations in 232 patients monitored over several
years point out that small-to-moderate size AA aneurysmsTABLE 2. Average diameters (centimeters) of the aorta in control and
surveillance groups
Surveillance group Control group
Sinotubular junction 4.1  0.6 3.0  0.4
Mid-ascending aorta 4.4  0.6 3.2  0.4
Arch 3.2  0.5 2.6  0.3
Descending aorta 2.9  0.5 2.5  0.3
Celiac axis 2.5  0.4 2.2  0.3
Renal arteries 2.2  0.3 2.1  0.3
Abdominal 2.1  0.4 1.8  0.5
All P values< .001, except for the renal arteries.
72 The Journal of Thoracic and Cardiovascular Surgegrow slowly and that the risk of rupture or dissection is
low. In our surveillance group of patients, we did not
observe a single fatal complication. Because size and
growth are independent risk factors for dissection and
rupture5,11; however, it is important to rely on accurate
measurements.
Previous studies of expansion of the thoracic aorta using
diameters report growth rates ranging from 0.10 cm/year to
0.42 cm/year for the thoracic aorta.8-13 Elefteriades and
Farkas13 report an overall growth rate of 0.12 cm/year for
the thoracic aorta, with the descending aorta growing faster
than the AA (0.3 vs 0.1 cm/year). These authors confirm our
observation with regard to patients under surveillance: Not
a single patient of theirs died of rupture in a group with
asymptomatic small aortic aneurysms, less than 5.5 cm in
diameter. Consensus seems to exist that the risk of rupture
is low for patients with small thoracic aneurysms.
Coady and colleagues5 performed growth rate estimates
in 79 patients according to initial aneurysm size. They not
only showed that descending aneurysm growth is faster
than growth in ascending aneurysms but also addressed
the question of whether growth rate is related to size: They
found that larger aneurysms at initial presentation grew
faster. Although this observation is supported by 2 earlier
studies,10,11 Coady and colleagues, in their multivariable
model, could not identify size as independently affecting
overall aneurysm growth rate, and Hirose and colleagues9
also did not support the idea that there is a certain threshold
of size that influences growth rate.
The growth rate that we measure in this series is an order
of magnitude lower than in all these previous studies. Avol-
ume increment of 1 mL/year translates into an increase in
diameter of only 0.02 cm/year for an AA aneurysm with a
length of 8.7 cm, the average estimated length in this series.
We are confident that our measurements are accurate,
although it is conceivable that there is some as yet
unexplained error in our determinations. We suggest that
the substantial difficulties in accurately measuring AA
diameter described earlier, combined with an understand-
able unconscious prejudice that growth must be occurring,
have resulted in a systematic overestimation of later mea-
surements in aneurysms examined serially. It could also
be that the ‘‘natural’’ history of AA aneurysm growth is
changing as the result of better medical therapy or self-
selection of patients who participate in surveillance. It
also should be pointed out that all our measurements were
collected prospectively, and consequently did not include
a look back at patients who came to medical attention
because of rupture/dissection, a possible methodological
flaw in some previous studies. Although it is true that the
size of the aneurysms in this group is modest, with an
average diameter of 4.4  0.6 cm at the time of the first
scan, neither we nor others have been able to demonstrate
an unequivocal influence of size on growth rate.ry c January 2014
FIGURE 6. We can see a normal distribution of aortic diameters in our patient population under surveillance. Given the small annual risk of rupture
(<0.1%-0.3%), it might be reasonable to suggest that similar patients with larger aneurysms, perhaps 1 SD greater (ie, 5.0 þ 0.6 cm), should be followed
closely rather than undergo elective resection.
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growth is that diameter may be a better predictor of rupture
risk than volume, given the dependency of wall tension on
diameter14: We concede that a long slim aorta may be less
dangerous than a short fat one of the same volume. We
would agree that diameters are important for describing
ascending aneurysms, but we would argue that changes in
diameter, given the problems cited, are unlikely to detect
growth accurately.
We observed a normal distribution of radiologically
measured AA diameters in our patient population under sur-
veillancewith an estimated mean SD for the AA diameter
of 4.4 0.6 cm (Figure 6). Approximately 95% of the sub-
jects had a diameter less than 5.4 cm. A surprising but
encouraging finding of this prospective study is that the
rupture/dissection risk of these small-to-moderate size an-
eurysms is extremely low: less than 0.1% to 0.3%. This im-
plies that—absent other indications—elective resection is
not indicated in this size range. Therefore, it might be
reasonable to suggest that a patient population with aneu-
rysms 1 SD larger—(5.0þ 0.6 cm) than in this series of sur-
veillance patients—could also be followed closely rather
than undergo elective resection. It would also seem that
annual scanning is likely not necessary for patients with an-
eurysms the size of those in the surveillance group. We
would suggest that biennial scanning be combined with
annual follow-up to measure blood pressure control, b-
blockade, and lifestyle modification, such as smoking
cessation.
Finally, an unexpected finding—that anticoagulant ther-
apy seems to inhibit AA growth—is difficult to explain. A
Danish study of 148 patients with small-to-moderate size
abdominal aortic aneurysms in 2008 also found thatThe Journal of Thoracic and Clow-dose aspirin was associated with decreased growth.
They considered the possibility that a change in lifestyle
in users of low-dose aspirin occurs, which prevents progres-
sion of disease.15 One could also invoke inhibition of micro-
thrombus formation in the intima in low-flow regions of the
aneurysm—with secondary inflammation—as a possible
explanation for why anticoagulants retard aneurysm expan-
sion. A confirmation of the correlation of anticoagulant use
with slower aneurysm growth in a prospective randomized
study would be appropriate before any change in therapeu-
tic recommendations.
CONCLUSIONS
CT volume measurements of the aorta provide an objec-
tive method of ascertaining aortic size and monitoring
expansion. Small-to-moderate size AA aneurysms in pa-
tients who are carefully followed and managed appropri-
ately, including the use of antihypertensive medications
and beta-blocking agents, have a slow rate of growth and
a small risk of rupture and dissection. Annual CT scanning
may not be required in this population, and elective resec-
tion, absent other surgical indications, is unnecessary. It
may be appropriate to consider surveillance and medical
management of patients with AA aneurysms somewhat
larger than those reported in this series.
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Dr Michael Fischbein (Stanford, Calif). Dr Griepp and his
research laboratory have been leaders in thoracic aortic surgery
and contributed so much both clinically and scientifically.
I have 3 questions. First, any given increase in the AA volume
can be secondary to (1) an increase in the maximum dimension
or (2) elongation of the aorta with no change in the maximum74 The Journal of Thoracic and Cardiovascular Surgedimension. Do you think these 2 situations have the same risk of
rupture?
Dr Geisbuesch. No. We do not think the risk of rupture is the
same. We know that wall tension increases with increased diam-
eter, so we believe that a short, fat aorta is more likely to rupture
than a long slim one.
Dr Fischbein. Second, tell us how you are using aortic volume
measurements at Mount Sinai. Are you using a combination of
both maximum dimension and volume change, and what exact vol-
ume change or rate of volume change are you using to determine if
someone should then proceed to surgery?
Dr Geisbuesch. The decision whether or not to operate on a
patient can of course never be based on a single measurement,
so at Mount Sinai we look at family history of rupture or dissec-
tion and other risk factors, as well as volume measurements in
combination with maximum dimension. In addition, we can
look at the ratio of AA volume to total aortic volume. If we
see a significant increase in volume in combination with an in-
crease in maximum diameter, depending on these other factors,
this would then lead to the decision to a short follow-up or to op-
erate on the patient electively.
The advantage of the volumemeasurement in this context is that
because it is an objective, reproducible measurement, it reliably
ascertains whether a change has really occurred and can pinpoint
the location of an enlargement, if present. In the event that no
change in volume is documented, we can be more confident than
with diameter measurements in reassuring the patient that no
growth has occurred, and that surgery is not needed.
Dr Fischbein. Third, can this program measuring volume
change be easily used universally? Can everyone adopt this new
format?
Dr Geisbuesch. Yes. We are convinced that volume measure-
ments can be performed at other institutions. As with every new
technique, there is certainly a learning curve to obtain accurate
measurements and achieve reliability, but from our experience
we can only say that if the technician goes back and repeats the
measurements, he/she gets the same results. The key to this is con-
sistency in how the CT scans are performed and the measurements
are undertaken. Once consistency has been achieved, I think CT
volume measurements are far more objective and reproducible
than measurements of diameter at a single level.ry c January 2014
